These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32284464)

  • 1. [Brain Tumor].
    Komori T
    Brain Nerve; 2020 Apr; 72(4):399-405. PubMed ID: 32284464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.
    Sonoda Y
    Int J Clin Oncol; 2020 Jun; 25(6):1004-1009. PubMed ID: 32020379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
    Rogers TW; Toor G; Drummond K; Love C; Field K; Asher R; Tsui A; Buckland M; Gonzales M
    J Neurooncol; 2018 Mar; 137(1):181-189. PubMed ID: 29218432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Classification of Diffuse Gliomas.
    Kalidindi N; Or R; Babak S; Mason W
    Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
    Malzkorn B; Reifenberger G
    Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
    Chen SC; Lo CM; Wang SH; Su EC
    BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance of molecular markers of adult diffuse glioma.
    Molinari E; Curran OE; Grant R
    Pract Neurol; 2019 Oct; 19(5):412-416. PubMed ID: 31175262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource-limited set-up.
    Rajeswarie RT; Rao S; Nandeesh BN; Yasha TC; Santosh V
    J Clin Pathol; 2018 Apr; 71(4):323-329. PubMed ID: 28801347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.
    Mur P; Mollejo M; Hernández-Iglesias T; de Lope ÁR; Castresana JS; García JF; Fiaño C; Ribalta T; Rey JA; Meléndez B
    J Neuropathol Exp Neurol; 2015 Mar; 74(3):241-9. PubMed ID: 25668564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic principles of diagnosis and treatment of gliomas].
    Wirsching HG; Weiss T; Roth P; Weller M
    Nervenarzt; 2018 Jun; 89(6):692-698. PubMed ID: 29679127
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Cicone F; Carideo L; Scaringi C; Arcella A; Giangaspero F; Scopinaro F; Minniti G
    Ann Nucl Med; 2019 Apr; 33(4):295-302. PubMed ID: 30607877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee.
    Preusser M; Capper D; Hartmann C;
    Clin Neuropathol; 2011; 30(5):217-30. PubMed ID: 21955925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
    J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse Gliomas for Nonneuropathologists: The New Integrated Molecular Diagnostics.
    Lee SC
    Arch Pathol Lab Med; 2018 Jul; 142(7):804-814. PubMed ID: 29775073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors.
    Sonoda Y; Yokoo H; Tanaka S; Kinoshita M; Nakada M; Nishihara H;
    Brain Tumor Pathol; 2019 Apr; 36(2):56-62. PubMed ID: 30847711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Classification of gliomas. Current progress and perspectives].
    Capper D; Reifenberger G
    Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR.
    Hirano M; Ohka F; Maeda S; Chalise L; Yamamichi A; Aoki K; Kato A; Tanahashi K; Motomura K; Nishimura Y; Hara M; Shinjo K; Kondo Y; Wakabayashi T; Natsume A
    Brain Tumor Pathol; 2018 Apr; 35(2):97-105. PubMed ID: 29460200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Static and dynamic
    Verger A; Stoffels G; Bauer EK; Lohmann P; Blau T; Fink GR; Neumaier B; Shah NJ; Langen KJ; Galldiks N
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):443-451. PubMed ID: 29043400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.